Cambia
Product Images NDC 50192-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cambia (NDC 50192-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nautilus Neurosciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclofenac Potassium Structural Formula (Cambia 01)

Diclofenac Potassium Structural Formula (Cambia 01)
Chemical structure diagram of the active ingredient in CAMBIA by Nautilus Neurosciences, Inc. The structure shows a potassium salt form with chlorinated aromatic rings and attached functional groups.*
FDA Label Image

Figure 1. Percentage Of Patients With Initial Headache Pain Freedom Within 2 Hours (Cambia 02)

Figure 1. Percentage Of Patients With Initial Headache Pain Freedom Within 2 Hours (Cambia 02)
A line graph comparing the percent of subjects over time between CAMBIA and placebo groups. The x-axis represents hours, ranging from 0 to over 2, while the y-axis shows percent of subjects up to 30%. Two step-like lines depict the changes over time for CAMBIA (solid line) and placebo (dashed line) groups.*
FDA Label Image

Principal Display Panelcambiadiclofenac Potassium For Oral Solution (Cambia 03)

Principal Display Panelcambiadiclofenac Potassium For Oral Solution (Cambia 03)
CAMBIA Diclofenac Potassium for Oral Solution 50 mg carton label from Nautilus Neurosciences, Inc. The label indicates oral solution dosage form with a 50 mg strength. Includes directions for use, warning about phenylketonurics, storage instructions, and barcode. Marked as sample and not for resale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.